199 related articles for article (PubMed ID: 6582963)
1. Risks in mass distribution of potassium iodide.
Yalow RS
Bull N Y Acad Med; 1983 Dec; 59(10):1020-7. PubMed ID: 6582963
[No Abstract] [Full Text] [Related]
2. Physiological basis for the use of potassium iodide as a thyroid blocking agent logistic issues in its distribution.
Becker DV
Bull N Y Acad Med; 1983 Dec; 59(10):1003-8. PubMed ID: 6582961
[No Abstract] [Full Text] [Related]
3. Indications for using potassium iodide to protect the thyroid from low level internal irradiation.
Robbins J
Bull N Y Acad Med; 1983 Dec; 59(10):1028-38. PubMed ID: 6582964
[No Abstract] [Full Text] [Related]
4. Recommendations on the use of potassium iodide as a thyroid-blocking agent in radiation accidents: an FDA update.
Shleien B; Halperin JA; Bilstad JM; Botstein P; Dutra EV
Bull N Y Acad Med; 1983 Dec; 59(10):1009-19. PubMed ID: 6582962
[No Abstract] [Full Text] [Related]
5. Nuclear power plant emergencies and thyroid cancer risk. What New Jersey physicians need to know.
Kahn LH; von Hippel F
N J Med; 2004 Apr; 101(4):22-7; quiz 28-30. PubMed ID: 15103787
[TBL] [Abstract][Full Text] [Related]
6. An anti-nuclear shield for your thyroid.
Johns Hopkins Med Lett Health After 50; 2002 Oct; 14(8):6-7. PubMed ID: 12425277
[No Abstract] [Full Text] [Related]
7. In accidents, give KI promptly.
Archer VE
Health Phys; 1985 Dec; 49(6):1311-3. PubMed ID: 4077539
[No Abstract] [Full Text] [Related]
8. Resolution concerning the stockpiling of potassium iodide in New York City in the event of a nuclear accident. The Committee on Public Health, The New York Academy of Medicine.
Bull N Y Acad Med; 1981 Jun; 57(5):395-9. PubMed ID: 6941832
[No Abstract] [Full Text] [Related]
9. Some aspects of emergency planning for nuclear reactor accidents by New York City.
Solon LR
Bull N Y Acad Med; 1983 Dec; 59(10):981-7. PubMed ID: 6582983
[No Abstract] [Full Text] [Related]
10. France distributes iodine near reactors.
Balter M
Science; 1997 Mar; 275(5308):1871-2. PubMed ID: 9122686
[No Abstract] [Full Text] [Related]
11. The use of iodine as a thyroidal blocking agent in the event of a reactor accident. Report of the Environmental Hazards Committee of the American Thyroid Association.
Becker DV; Braverman LE; Dunn JT; Gaitan E; Gorman C; Maxon H; Schneider AB; Van Middlesworth L; Wolff J
JAMA; 1984 Aug; 252(5):659-61. PubMed ID: 6737670
[TBL] [Abstract][Full Text] [Related]
12. [Iodine prophylaxis following nuclear accidents].
Jaworska A
Tidsskr Nor Laegeforen; 2007 Jan; 127(1):28-30. PubMed ID: 17205086
[TBL] [Abstract][Full Text] [Related]
13. Consideration of potassium iodide in emergency plans. Nuclear Regulatory Commission. Final rule.
Fed Regist; 2001 Jan; 66(13):5427-40. PubMed ID: 11503776
[TBL] [Abstract][Full Text] [Related]
14. Reactor accidents. Public health strategies and their medical implications.
Becker DV
JAMA; 1987 Aug; 258(5):649-54. PubMed ID: 3612987
[TBL] [Abstract][Full Text] [Related]
15. Iodide.
Waterfall WK
Br Med J; 1980 Oct; 281(6246):988-9. PubMed ID: 7427554
[No Abstract] [Full Text] [Related]
16. Potassium iodide for thyroid blockade in a reactor accident: administrative policies that govern its use.
Becker DV; Zanzonico P
Thyroid; 1997 Apr; 7(2):193-7. PubMed ID: 9133683
[TBL] [Abstract][Full Text] [Related]
17. Distributing KI pills to minimize thyroid radiation exposure in case of a nuclear accident in France.
Le Guen B; Stricker L; Schlumberger M
Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):611. PubMed ID: 17710083
[No Abstract] [Full Text] [Related]
18. [Environmental contamination by iodine-131 and cancer of the thyroid gland].
Pepe M; Di Perna P; Re M; Sorcini G; Falcone M; Russo G; Scibinetti F; Clemenzia G; Gallo G; Amici A
Minerva Med; 1988 Mar; 79(3):215-7. PubMed ID: 3362401
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced thyroid cancer--what's new?
Boice JD
J Natl Cancer Inst; 2005 May; 97(10):703-5. PubMed ID: 15900034
[No Abstract] [Full Text] [Related]
20. Risk of thyroid cancer after exposure to 131I in childhood.
Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
